Literature DB >> 22871495

The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma.

Lingchao Chen1, Wei Zhang, Wei Yan, Lei Han, Kailiang Zhang, Zhendong Shi, Junxia Zhang, Yongzhi Wang, Yongli Li, Shizhu Yu, Peiyu Pu, Chuanlu Jiang, Tao Jiang, Chunsheng Kang.   

Abstract

Notch pathway plays critical role in stem cell maintenance and angiogenesis, as well as cell fate decisions of cancer. However, concrete mechanisms of notch pathway regulation in glioma were not well known, especially mediated by microRNAs. In this study, we identified a brain-specific miRNA, miR-524-5p, which was associated with the pathological grade and overall survival of gliomas. Restorated expression of miR-524-5p in glioma suppressed cell proliferation and invasion both in vitro and in vivo. Using bioinformatics and biological approaches, we found that Jagged-1 and Hes-1, two key components of notch pathway, were direct targets of miR-524-5p. Knocking down of Jagged-1 or Hes-1 partially phenocopied miR-524-5p re-expression, whereas forced expression of Jagged-1 or Hes-1 reversed the effects of miR-524-5p on proliferation and invasion of glioma. Moreover, miR-524-5p levels in glioma samples were inversely correlated with Jagged-1 and Hes-1 and their overexpressions were associated with poor survival. Thus, we have identified that miR-524-5p behaves as a tumor suppressor by negatively targeting Jagged-1 and Hes-1 and provides an additional option to inhibit this oncogene in gliomas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22871495     DOI: 10.1093/carcin/bgs261

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  39 in total

1.  Hypoxia-induced microRNA-301b regulates apoptosis by targeting Bim in lung cancer.

Authors:  Duoguang Wu; Baishen Chen; Fei Cui; Xiaotian He; Wenjian Wang; Minghui Wang
Journal:  Cell Prolif       Date:  2016-06-28       Impact factor: 6.831

2.  Expression Profile of Selected MicroRNAs in the Peripheral Blood of Multiple Sclerosis Patients: a Multivariate Statistical Analysis with ROC Curve to Find New Biomarkers for Fingolimod.

Authors:  Mohammad Mahdi Eftekharian; Alireza Komaki; Mehrdokht Mazdeh; Shahram Arsang-Jang; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  J Mol Neurosci       Date:  2019-03-21       Impact factor: 3.444

Review 3.  Micro-masters of glioblastoma biology and therapy: increasingly recognized roles for microRNAs.

Authors:  Desiree Floyd; Benjamin Purow
Journal:  Neuro Oncol       Date:  2014-04-10       Impact factor: 12.300

Review 4.  Hes1: the maestro in neurogenesis.

Authors:  Sivadasan Bindu Dhanesh; Chandramohan Subashini; Jackson James
Journal:  Cell Mol Life Sci       Date:  2016-05-27       Impact factor: 9.261

Review 5.  Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions.

Authors:  Diogo Libânio; Mário Dinis-Ribeiro; Pedro Pimentel-Nunes
Journal:  World J Clin Oncol       Date:  2015-10-10

6.  SP1-mediated microRNA-520d-5p suppresses tumor growth and metastasis in colorectal cancer by targeting CTHRC1.

Authors:  Li Yan; Jiang Yu; Fei Tan; Geng-Tai Ye; Zhi-Yong Shen; Hao Liu; Yan Zhang; Jie-Fu Wang; Xian-Jun Zhu; Guo-Xin Li
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

Review 7.  Extracellular Vesicles and MicroRNAs: Their Role in Tumorigenicity and Therapy for Brain Tumors.

Authors:  Agnieszka Bronisz; Jakub Godlewski; E Antonio Chiocca
Journal:  Cell Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.046

Review 8.  Current progress for the use of miRNAs in glioblastoma treatment.

Authors:  Amanda Tivnan; Kerrie Leanne McDonald
Journal:  Mol Neurobiol       Date:  2013-04-28       Impact factor: 5.590

Review 9.  The Notch signaling pathway as a mediator of tumor survival.

Authors:  Kathleen M Capaccione; Sharon R Pine
Journal:  Carcinogenesis       Date:  2013-04-12       Impact factor: 4.944

10.  MicroRNA-524-5p suppresses the growth and invasive abilities of gastric cancer cells.

Authors:  Guang-Hui Liu; Yuan-Hua Liu; Zhen Yang; A-Li Zhu; Chun-Lin Zhao
Journal:  Oncol Lett       Date:  2016-01-26       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.